Financial Performance - Operating revenue for the reporting period was CNY 547,080,607.96, representing a 21.24% increase year-on-year[8]. - Net profit attributable to shareholders was CNY 44,136,222.67, a 2.48% increase compared to the same period last year[8]. - Net profit attributable to shareholders after deducting non-recurring gains and losses increased by 69.95% to CNY 41,438,942.06[8]. - Basic earnings per share for the reporting period was CNY 0.1069, a 0.94% increase year-on-year[8]. - The company's operating revenue for the year-to-date reached ¥1,402,233,799.37, representing a 13.08% increase compared to ¥1,240,055,722.52 in the same period last year[21]. - Net profit for the period was ¥107,582,245.37, reflecting an 11.37% increase from ¥96,600,227.75 year-on-year, driven by improved performance in the feed enzyme segment and reduced interest expenses[21]. - The total operating income for the year-to-date period reached CNY 1,402,233,799.37, an increase of 13.1% from CNY 1,240,055,722.52 in the previous year[48]. - The net profit for the year-to-date period was CNY 107,582,245.37, compared to CNY 96,600,227.75 in the same period last year, reflecting a growth of 11.5%[50]. Cash Flow - Cash flow from operating activities for the year-to-date was CNY 245,159,458.95, an increase of 145.42%[8]. - Cash flow from operating activities increased significantly to ¥245,159,458.95, a 145.42% rise from ¥99,893,884.00 in the previous year, attributed to increased accounts payable and the use of bank acceptance bills for payments[21]. - The cash flow from operating activities generated a net amount of ¥245,159,458.95, compared to ¥99,893,884.00 in the previous year, indicating a growth of 145.0%[58]. - The net cash flow from operating activities was -241,741,112.39 CNY, compared to 66,504,849.49 CNY in the previous period, indicating a significant decline in operational cash generation[62]. Assets and Liabilities - Total assets at the end of the reporting period decreased by 5.07% to CNY 4,557,677,610.60 compared to the end of the previous year[8]. - The company's cash and cash equivalents decreased significantly to CNY 214,123,056.41 from CNY 938,479,567.55, indicating a decline of approximately 77%[32]. - Total liabilities decreased to CNY 741,783,477.46 from CNY 1,194,951,600.78, a reduction of 37.9%[39]. - The company's total liabilities decreased to CNY 1,930,236,940.41 from CNY 2,394,425,839.26, indicating a decline of approximately 19.4%[34]. - Total current liabilities decreased to CNY 1,198,620,545.03 from CNY 1,442,576,384.69, a reduction of about 16.9%[34]. Shareholder Information - The company reported a total of 13,472 common shareholders at the end of the reporting period[12]. - The largest shareholder, Zhuhai Jindadi Investment Co., Ltd., held 32.99% of the shares, amounting to 141,615,094 shares[12]. - The equity attributable to the owners of the parent company increased to CNY 2,355,240,949.66 from CNY 2,142,005,405.16, showing a growth of about 9.9%[35]. Research and Development - The company reported a significant increase in research and development expenses, which rose to CNY 28,861,888.10 from CNY 20,022,946.57, marking a 44.1% increase[42]. - Research and development expenses increased to CNY 7,284,711.34, up 38.4% from CNY 5,264,517.90 in the previous year[46]. - Research and development expenses increased to ¥17,052,434.85, up from ¥13,556,031.39, representing a rise of 25.0% year-over-year[54]. Investment Activities - The company’s investment activities generated a cash outflow of ¥296,054,984.19, a 91.13% increase from the previous year, driven by investments in various production projects[21]. - The company reported an investment income of ¥48,870,201.00, which is a substantial increase from ¥23,055,760.35 in the previous year, reflecting a growth of 111.3%[54]. Operational Costs - The company reported a 14.42% increase in operating costs, totaling ¥906,743,805.10, in line with the growth in operating revenue[21]. - Total operating costs for Q3 2019 were CNY 485,812,379.92, up from CNY 415,687,483.92 in the same period last year, reflecting a growth of 16.8%[42]. - The total operating costs for the year-to-date period were CNY 1,291,478,408.83, up from CNY 1,158,317,411.30 in the previous year[48].
溢多利(300381) - 2019 Q3 - 季度财报